Advertisement

  • News
  • Columns
  • Interviews
  • BW Communities
  • Events
  • BW TV
  • Subscribe to Print
  • Editorial Calendar 19-20

Latest Articles in pharmaceutical

“The Big Indian Pli Scheme –Will It Be An Elusive Dream For India’s Tv Manufacturers ?”

India is a very price-sensitive market, its noteworthy to mention that most of the 32inch smart TV that were available for anywhere starting Rs 10,000 onwards are already retailing upwards of Rs 14,000.

Read More

Pfizer COVID-19 Vaccine Reduces Transmission After One Dose - UK Study

Britain has been rolling out vaccinations with both the Pfizer COVID-19 shot and one from AstraZeneca since late December 2020.

Read More

Govt Continuously Working To Improve Ease Of Doing Biz In Pharma Sector: Minister

'Indian pharma industry can achieve the ambitious target which it has set for itself for reaching an annual turnover of USD 130 billion by 2030. Similarly, the medical device industry in the country has the potential to grow to about USD 50 billion by 2025,'

Read More

Bayer Fourth-Quarter Core Earnings Below Market View On Forex Hit

Adjusted EBITDA at its agriculture unit fell 30% to 594 million euros, dragged lower by 450 million euros in negative currency effects and also hurt by competition in U.S. weed killer market.

Read More

Biocon Biologics To Partner With International Diabetes Federation

Global Head of Market Access & Policy, Biocon Biologics, Alexander Zach, said:'Given our extensive experience in providing affordable insulins globally, we believe we can contribute and support IDF in driving real policy and access actions that will transform lives and diabetes care.

Read More

Blue Star to set up Rs 130 crore plant, expand commercial refrigeration footprint

Blue Star to set up Rs 130 crore plant, expand commercial refrigeration footprint

Read More

India Pesticides Files Rs 800-Cr IPO Papers

The Uttar Pradesh-based company may decide to undertake a pre-IPO placement of Rs 75 crore subject to consultation of the merchant bankers.

Read More

UK Delegation Visits Serum Institute

'We discussed how to further enhance the existing relationship between India and the UK on manufacturing and innovation in the healthcare space.'

Read More

PE Firm Advent To Buy Controlling Stake In ZCL Chemicals At Enterprise Value Of Rs 1,700 Cr

Advent has committed over USD 1.2 billion globally across the healthcare sector and USD 600 million in four Indian companies into healthcare, consumer, and financial services

Read More

Higher Allocation For Infrastructure In Budget

The Railway ministry has got a 53% increase in capital expenditure allocation for developing stations, improving rail connectivity, rail electrification and also for executing Metro and Rapid Rail Transport Systems.

Read More

India, 'Pharmacy Of The World', Starts COVID Vaccine Shipments To Neighbours

India authorised two vaccines this month for emergency use at home, one licensed from Oxford University and AstraZeneca and another developed at home by Bharat Biotech in partnership with the state-run Indian Council of Medical Research.

Read More

DGCI Approves The Vaccines By Serum Institute Of India And Bharat Biotech

Both the vaccines can be stored at 2-8 degrees, and the companies have been stockpiling of over 50 million doses at the moment, assuring that soon they will be manufacturing more dosage of the vaccine.

Read More

Brazil Scrambles For India-Made Vaccines To Jumpstart Inoculations

Bharat Biotech has not yet applied for approval by Brazil's health regulator Anvisa for its Covaxin vaccine, and the agency said it would have to undergo Phase III trials in the country.

Read More

India Approves AstraZeneca's COVID-19 Vaccine

India's Central Drugs Standard Control Organization (CDSCO) is expected to announce the dosage and other details about the shot later. SII had applied for a two full-dose regime about 28 days apart.

Read More

Drugmakers To Hike Prices For 2021 As Pandemic, Political Pressure Put Revenues At Risk

Teva Pharmaceuticals Inc hiked prices on 15 drugs, including Austedo, which treats rare neurological disorders, and asthma steroid Qvar, which together grossed more than $650 million in sales in 2019 and saw price hikes of between 5% and 6%.

Read More